Portraits et souvenirs.

Portraits: Hector Berlioz. Franz Liszt. Charles Gounod. Victor Massé. Antoine Rubinstein.--Souvenirs: Une traversée en Bretagne. Un engagement d'artiste. Georges Bizet. Louis Gallet. Docteur à Cambridge. "Orphée." Don Giovanni--Variétés: La defense de l'opéra-comique. Drame lyrique et drame musical. Le théâtre au concert. L'illusion wagnérienne. Le mouvement musical. Lettre des Las Palmas.

Chronicon antiquum sacri monasterij Cassinensis, olim à Leone cardinali, & episcopo Ostiensi conscriptum: nunc vero à reuerendo patre d. Matthaeo Laureto ... recognitum, & pristinae integritati restitutum, ac pluribus adnotationibus illustratum, & auctum. Adiecta insuper, ab eodem auctore, breui De monachatu S. Gregorij Magni, sub regula S. Benedicti, disputatione.

Mode of access: Internet.

Shan'gu dao bi : 20 juan /

Block print.

Shan'gu ti ba : 4 juan /

Block print.

A teaching method for brain-injured and hyperactive children; a demonstration-pilot study

"Research ... pursuant to contract SAE-6415, United States Office of Education, Department of Health, Education, and Welfare."

Fifteen songs, low. /

Text in English and French.

Samson et Delilah : opera in three acts /

Melodies to principal arias included.

Hélène : Helen of Troy : lyric poem in one act /

Mode of access: Internet.

Automotive engineering

Mode of access: Internet.

Clean Air Act Amendments of 1989 : hearing before the Subcommittee on Environmental Protection of the Committee on Environment and Public Works, United States Senate, One Hundred First Congress, first session ...

Item 1045-A, 1045-B (MF)

Superfund implementation : hearings before the Subcommittee on Superfund and Environmental Oversight of the Committee on Environment and Public Works, United States Senate, One hundredth Congress, first session, April 14, 1987, Newark, N.J.; April 29, June 25, and July 23, 1987, Washington, D.C.

Item 1045-A, 1045-B (microfiche)

Coastal Barrier Resources Act : hearings before the Subcommittee on Environmental Pollution of the Committee on Environment and Public Works, United States Senate, Ninety-seventh Congress, first and second sessions on S. 1018 ... August 13, 1981-Providence, R.I., October 21, 1981-Washington, D.C., February 3, 1982-Washington, D.C.

Item 1045-A, 1045-B (microfiche).

Resource Conservation and Recovery Act--oversight : hearings before the Subcommittee on Hazardous Wastes and Toxic Substances of the Committee on Environment and Public Works, United States Senate, One Hundredth Congress, first session.

Item 1045-A, 1045-B (microfiche).

Allgemeines bibliographisches lexikon.

"Verzeichniss der Elzevier'schen drucke von griechischen und lateinischen classikern und kirchenvatern, in duodez und in kleinerm format": v. 2, col. 1109-1116.

Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)

Aims The study estimated serious adverse event (SAE) rates among entrants to pharmacotherapies for opioid dependence, during treatment and after leaving treatment. Design A longitudinal study based on data from 12 trials included in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Participants and settings A total of 1.244 heroin users and methadone patients treated in hospital, community and GP settings. Intervention Six trials included detoxification; all included treatment with methadone, buprenorphine, levo-alpha-acetyl-methadol (LAAM) or naltrexone. Findings During 394 person-years of observation, 79 SAEs of 28 types were recorded. Naltrexone participants experienced 39 overdoses per 100 person-years after leaving treatment (44% occurred within 2 weeks after stopping naltrexone). This was eight times the rate recorded among participants who left agonist treatment. Rates of all other SAEs were similar during treatment versus out of treatment, for both naltrexone-treated and agonist-treated participants. Five deaths occurred, all among participants who had left treatment, at a rate of six per 100 person-years. Total SAE rates during naltrexone and agonist treatments were similar (20, 14 per 100 person-years, respectively). Total SAE and death rates observed among participants who had left treatment were three and 19 times the corresponding rates during treatment. Conclusions Individuals who leave pharmacotherapies for opioid dependence experience higher overdose and death rates compared with those in treatment. This may be due partly to a participant self-selection effect rather than entirely to pharmacotherapy being protective. Clinicians should alert naltrexone treatment patients in particular about heroin overdose risks. Duty of care may extend beyond cessation of dosing.